In recent legislative terms, Mississippi introduced bills that sought to increase price transparency, including HB 737 (2019), which requires Managed Care plans to include certain fee schedules to providers, establish a physician advisory committee, and establish a billing dispute external review process, and HB 483, which regulates balance billing of facility-based physicians. Additionally, HB 283 would prohibit price gouging of essential drugs. However, none of these initiatives passed at the end of the term.
In the 2018 legislative session, Mississippi introduced several bills to improve price transparency and cost containment for prescription drugs. While most failed to pass, the legislature passed the Prescription Drug Consumer Affordable Alternative Payment Options Act (HB 709), which allows pharmacists to provide patients with information about affordable alternatives of drugs.
2020 Legislative Session: 1/7/2020 - 5/10/2020 (2020 term). *Current session bill updates are ongoing. Check back weekly for updates.
STATE BUDGETThe State of Mississippi fiscal year runs from July 1 through June 30. Mississippi enacted its FY 2020 Budget in the 2019 regular legislative session. To view Mississippi’s FY 2020 appropriation bulletin, click here.
REGULATION & ENFORCEMENT
- Mississippi was one of 16 states to file an amicus brief supporting the FTC’s winning position in the Ninth Circuit appeal of St. Luke’s Health Care Sys. v. FTC, No. 14-35173 (March 7, 2014), decided February 10, 2015. The States’ brief stated that the acceleration of health care costs due to the growth of large health care provider systems had become a matter of grave concern for the states.